Neural cell adhesion molecule expression: Prognosis in 889 patients with resected non-small cell lung cancer

Chest

Volumn 114, Issue 5, 1998, Pages 1316-1320

  Hage, René ^a   Elbers, Hans R J ^a   De La Rivière, Aart Brutel ^a   Van Den Bosch, Jules M M ^a  

^a ST ANTONIUS HOSPITAL   (Netherlands)

Author keywords

Lung cancer, NCAM, neuroendocrine differentiation; Prognosis

Indexed keywords

NERVE CELL ADHESION MOLECULE;

ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; NEUROSECRETORY CELL; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031766678     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.114.5.1316     Document Type: Article

References (16)

1. Schol DJ, Mooi WJ, van der Gugten AA, et al. Monoclonal antibody 123C3, identifying small cell carcinoma phenotype in lung tumours, recognizes mainly, but not exclusively, endocrine and neuron-supporting normal tissues. Int J Cancer 1988; 2:34-40
2. Kibbelaar RE, Moolenaar KEC, Michalides RJAM, et al. Neural cell adhesion molecule expression, neuroendocrine differentiation and prognosis in lung carcinoma. Eur J Cancer 1991; 27:431-435
3. Mooi WJ, Wagenaar SS, Schol D, et al. Monoclonal antibody 123C3 in lung tumour classification: immunohistology of 358 resected lung tumours. Mol Cell Probes 1998; 2:31-37
4. Pujol JL, Simony J, Demoly P, et al. Neural cell adhesion molecule and prognosis of surgically resected lung cancer. Am Rev Respir Dis 1993; 148:1071-1075
5. Kwa HB, Michalides RJAM, Dijkman JH, et al. The prognostic value of NCAM, p53 and cyclin D1 in resected non-small cell lung cancer. Lung Cancer 1996; 14:207-217
6. Kwa HB, Verheijen GMM, Litvinov SV, et al. Prognostic factors in resected non-small cell lung cancer: an immunohistochemical study of 39 cases. Lung Cancer 1996; 16:34-45
7. The World Health Organization histological typing of lung tumours. 2nd ed. Am J Clin Pathol 1982; 77:13-136
8. Hirsch FR, Matthews MJ, Aisner S, et al. Histopathologic classification of small cell lung cancer: changing concepts and terminology. Cancer 1988; 62:973-977
9. Mountain CF. A new international staging system for lung cancer. Chest 1986; 89:225S-233S
10. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53:457-481
11. Peto R, Peto J. Asymptotically efficient rank invariant test procedures. J R Statist Soc (Series A) 1972; 135:185-198
12. Berendsen HH, de Leij L, Poppema S, et al. Clinical characterization of non-small cell lung cancer tumors showing neuroendocrine differentiation features. J Clin Oncol 1989; 7:1614-1620
13. Sundaresan V, Reeve JG, Stenning S, et al. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours. Br J Cancer 1991; 64:333-338
14. Graziano SL, Tatum AH, Newman NB, et al. The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer. Cancer Res 1994; 54:2908-2913
15. Graziano SL, Mazid R, Newman N, et al. The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer. J Clin Oncol 1989; 7:1398-1406
16. Travis WD, Linnoila RI, Tsokos MG, et al. Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma: an ultrastructural, immunohistochemical and flow cytometric study of 35 cases. Am J Surg Pathol 1991; 15:529-553